Lexeo Therapeutics, Inc. (LXEO) Tops Q3 EPS by 51c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q3 EPS of ($0.33), $0.51 better than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance